These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23873647)

  • 1. Tissue penetration and antimicrobial activity of standard- and high-dose trimethoprim/sulfamethoxazole and linezolid in patients with diabetic foot infection.
    Stein GE; Throckmorton JK; Scharmen AE; Weiss WJ; Prokai L; Smith CL; Havlichek DH
    J Antimicrob Chemother; 2013 Dec; 68(12):2852-8. PubMed ID: 23873647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections.
    Stein GE; Schooley S; Peloquin CA; Missavage A; Havlichek DH
    J Antimicrob Chemother; 2007 Oct; 60(4):819-23. PubMed ID: 17673476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid concentrations in infected soft tissue and bone following repetitive doses in diabetic patients with bacterial foot infections.
    Traunmüller F; Schintler MV; Spendel S; Popovic M; Mauric O; Scharnagl E; Joukhadar C
    Int J Antimicrob Agents; 2010 Jul; 36(1):84-6. PubMed ID: 20456925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported in diabetic patients.
    Gonzalez N; Sevillano D; Alou L; Cafini F; Gimenez MJ; Gomez-Lus ML; Prieto J; Aguilar L
    J Antimicrob Chemother; 2013 Oct; 68(10):2291-5. PubMed ID: 23674766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
    Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
    Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis.
    Stein GE; Schooley SL; Peloquin CA; Kak V; Havlichek DH; Citron DM; Tyrrell KL; Goldstein EJ
    Ann Pharmacother; 2005 Mar; 39(3):427-32. PubMed ID: 15701775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
    Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
    Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections.
    MacGowan AP
    J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii17-25. PubMed ID: 12730139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations.
    Tsuji BT; Bulitta JB; Brown T; Forrest A; Kelchlin PA; Holden PN; Peloquin CA; Skerlos L; Hanna D
    J Antimicrob Chemother; 2012 Sep; 67(9):2182-90. PubMed ID: 22685161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased serum linezolid concentrations in two patients receiving linezolid and rifampicin due to bone infections.
    Hoyo I; Martínez-Pastor J; Garcia-Ramiro S; Climent C; Brunet M; Cuesta M; Mensa J; Soriano A
    Scand J Infect Dis; 2012 Jul; 44(7):548-50. PubMed ID: 22385321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linezolid pharmacokinetics and pharmacodynamics in clinical treatment.
    Dryden MS
    J Antimicrob Chemother; 2011 May; 66 Suppl 4():iv7-iv15. PubMed ID: 21521707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro activity of linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus].
    Pérez L; Alarcón T; Jiménez S; de Las Cuevas MC; López-Brea S
    Rev Esp Quimioter; 2001 Mar; 14(1):47-50. PubMed ID: 11376349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid in the central nervous system: comparison between cerebrospinal fluid and plasma pharmacokinetics.
    Viaggi B; Paolo AD; Danesi R; Polillo M; Ciofi L; Del Tacca M; Malacarne P
    Scand J Infect Dis; 2011 Sep; 43(9):721-7. PubMed ID: 21585240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of linezolid in human non-inflamed vitreous after systemic administration.
    Horcajada JP; Atienza R; Sarasa M; Soy D; Adán A; Mensa J
    J Antimicrob Chemother; 2009 Mar; 63(3):550-2. PubMed ID: 19109336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentration of co-trimoxazole during a high-dosage regimen.
    Muhammed Ameen S; Rolain JM; Le Poullain MN; Roux V; Raoult D; Drancourt M
    J Antimicrob Chemother; 2014 Mar; 69(3):757-60. PubMed ID: 24123429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
    Murillo O; Doménech A; Garcia A; Tubau F; Cabellos C; Gudiol F; Ariza J
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4011-7. PubMed ID: 17015630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus.
    Leonard SN; Kaatz GW; Rucker LR; Rybak MJ
    J Antimicrob Chemother; 2008 Dec; 62(6):1305-10. PubMed ID: 18801920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral bioavailability of linezolid before and after Roux-en-Y gastric bypass surgery: is dose modification necessary in obese subjects?
    Hamilton R; Thai XC; Ameri D; Pai MP
    J Antimicrob Chemother; 2013 Mar; 68(3):666-73. PubMed ID: 23160755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aqueous and vitreous penetration of linezolid and levofloxacin after oral administration.
    George JM; Fiscella R; Blair M; Rodvold K; Ulanski L; Stokes J; Blair N; Pontiggia L
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):579-86. PubMed ID: 20977368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
    Kaka AS; Rueda AM; Shelburne SA; Hulten K; Hamill RJ; Musher DM
    J Antimicrob Chemother; 2006 Sep; 58(3):680-3. PubMed ID: 16840428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.